SCHEMBL4968751

SCHEMBL4968751

CCCCOC(=O)N1CC(C[O])C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.53
POLB P06746 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
ALDH1A1 P00352 2/20 0.42
GBA2 Q9HCG7 1/20 0.41
ATM Q13315 1/20 0.40
TSHR P16473 2/20 0.38
HPGD P15428 2/20 0.38
HRH2 P25021 1/20 0.37
HRH1 P35367 1/20 0.37
BCHE P06276 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNA4 P43681 1/20 0.37
HCAR2 Q8TDS4 1/20 0.36
NAAA Q02083 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
ESR1 P03372 1/20 0.35
KDM4E B2RXH2 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4968757 0.86 LMNA (0.53) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL30129908 0.85 LMNA (0.51) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL30129902 0.85 LMNA (0.51) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL6627450 0.84 LMNA (0.54) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL29655416 0.83 LMNA (0.50) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL3652718 0.82 LMNA (0.56) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL18498621 0.82 LMNA (0.56) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL20912047 0.82 POLB (0.56) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL1633241 0.82 LMNA (0.56) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL30711555 0.82 LMNA (0.49) LMNAPOLBSMN1; SMN2ALDH1A1GBA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966159-A2 CHEMICAL COMPOUNDS AstraZeneca AB (SE) 2008-09-10 EP disclosed
WO-2007071963-A2 QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2007-06-28 WO disclosed